UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of a model of data-flows for precision agriculture based on a collaborative research project

Computers and electronics in agriculture, 2009-04, Vol.66 (1), p.25-37

2009

Volltextzugriff (PDF)

CNES and ESOC Flight Dynamics Operational Experience on First Nominal FOC Launch and Fine Positioning Activities of GALILEO

Space Operations: Contributions from the Global Community, p.615-643

Volltextzugriff (PDF)

Flächenauswahl und Ökosystemares Monitoring in den Biosphärenreservaten Schorfheide-Chorin und Spreewald

Umweltwissenschaften und Schadstoff-Forschung, 2000-11, Vol.12 (6), p.362-372

2000

Volltextzugriff (PDF)

The number of stem cell transplantations during the COVID-19 pandemic

Deutsches Ärzteblatt international, 2022-09

2022

Volltextzugriff (PDF)

Effect of inferior caval valve implantation on circulating immune cells and inflammatory mediators in severe tricuspid regurgitation

BMC cardiovascular disorders, 2024-07, Vol.24 (1), p.1-10, Article 373

2024

Volltextzugriff (PDF)

Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit

Bone marrow transplantation (Basingstoke), 2013-11, Vol.48 (12), p.1548-1553

2013

Volltextzugriff (PDF)

Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system

Blood, 2011-08, Vol.118 (6), p.1685-1692

2011

Volltextzugriff (PDF)

A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL

Blood, 2021-05, Vol.137 (19), p.2646-2656

2021

Volltextzugriff (PDF)

The Number of Stem Cell Transplantations During the COVID-19 Pandemic

Deutsches Ärzteblatt international, 2022-09, Vol.119 (35-36), p.601-602

2022

Volltextzugriff (PDF)

A prospective study on serum Cytokeratin

Leukemia, 2018-12, Vol.32 (12), p.2685

2018

Volltextzugriff (PDF)

The Ig Superfamily Ligand B7H6 Subjects Activated T Cells to NK Cell Surveillance and Limits CAR T Cell Persistence

Blood, 2023-11, Vol.142 (Supplement 1), p.4830-4830

2023

Volltextzugriff (PDF)

Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)

Journal of clinical oncology, 2024-09

2024

Volltextzugriff (PDF)

A prospective study on serum Cytokeratin (CK)-18 and CK18 fragments as biomarkers of acute hepato-intestinal GVHD

Leukemia, 2018-12, Vol.32 (12), p.2685-2692

2018

Volltextzugriff (PDF)

Predictive performance of multi-model ensemble forecasts of COVID-19 across European nations

eLife, 2023-04, Vol.12

2023

Volltextzugriff (PDF)

A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL

Blood, 2021-05 (2020008825)

2021

Volltextzugriff (PDF)

Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT

Blood, 2013-03, Vol.121 (13), p.2529-2532

2013

Volltextzugriff (PDF)

Allogeneic haematopoietic cell transplantation offers the chance of cure for patients with transformed follicular lymphoma

Journal of cancer research and clinical oncology, 2018-06, Vol.144 (6), p.1173-1183

2018

Volltextzugriff (PDF)

Unrelated and alternative donor allogeneic stem cell transplant in patients with relapsed or refractory Hodgkin lymphoma: a systematic review

Leukemia & lymphoma, 2014-02, Vol.55 (2), p.296-306

2014

Volltextzugriff (PDF)

The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance

Science immunology, 2024-05, Vol.9 (95), p.eadj7970

2024

Volltextzugriff (PDF)

234 - Patient-Reported Outcomes (PROs) in Zuma-7, a Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard-of-Care (SOC) Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphoma (LBCL)

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S190-S191

2022

Volltextzugriff (PDF)

Patient-Reported Outcomes (PROs) in Zuma-7, a Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard-of-Care (SOC) Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphoma (LBCL)

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S190-S191

2022

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(31)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Humans
(13)
Hematology
(10)
Female
(9)
Male
(8)
Adult
(7)
Middle Aged
(7)
Biological And Medical Sciences
(6)
Retrospective Studies
(6)
Aged
(5)
Transplantation
(5)
Hematopoietic Stem Cell Transplantation - Methods
(4)
Medical Sciences
(4)
Oncology
(4)
Patients
(4)
Risk Factors
(4)
Stem Cell Transplantation
(4)
Survival Analysis
(4)
Adolescent
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Development of a model of data-flows for precision agriculture based on a collaborative research project

CNES and ESOC Flight Dynamics Operational Experience on First Nominal FOC Launch and Fine Positioning Activities of GALILEO

Flächenauswahl und Ökosystemares Monitoring in den Biosphärenreservaten Schorfheide-Chorin und Spreewald

The number of stem cell transplantations during the COVID-19 pandemic

Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial

Effect of inferior caval valve implantation on circulating immune cells and inflammatory mediators in severe tricuspid regurgitation

Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit

Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system

A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL

The Number of Stem Cell Transplantations During the COVID-19 Pandemic

A prospective study on serum Cytokeratin

The Ig Superfamily Ligand B7H6 Subjects Activated T Cells to NK Cell Surveillance and Limits CAR T Cell Persistence

Results of the Astral Study: A Prospective Phase II Clinical Study of the German Lymphoma Alliance to Assess the Efficacy and Toxicity of High-Dose Chemotherapy Followed By Allogeneic Stem Cell Transplantation As Treatment of Primary Progressive and Relapsed Aggressive Non-Hodgkin Lymphoma

High‐dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL‐GITMO

Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)

A prospective study on serum Cytokeratin (CK)-18 and CK18 fragments as biomarkers of acute hepato-intestinal GVHD

Predictive performance of multi-model ensemble forecasts of COVID-19 across European nations

Allogeneic Stem Cell Transplantation in Patients Aged ≥70 Years: Epidemiology, Outcomes, and Risk Factors Based on the German Registry for Stem Cell Transplantation (DRST)

A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL

Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT

Allogeneic haematopoietic cell transplantation offers the chance of cure for patients with transformed follicular lymphoma

Unrelated and alternative donor allogeneic stem cell transplant in patients with relapsed or refractory Hodgkin lymphoma: a systematic review

The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance

234 - Patient-Reported Outcomes (PROs) in Zuma-7, a Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard-of-Care (SOC) Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphoma (LBCL)

Patient-Reported Outcomes (PROs) in Zuma-7, a Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard-of-Care (SOC) Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphoma (LBCL)

Suchergebnisse filtern